Entry Detail



General Information

Database ID:exR0090490
RNA Name:hsa-miR-873-5p
RNA Type:miRNA
Chromosome:chr9
Starnd:-
Coordinate:
Start Site(bp):28888925End Site(bp):28888945
External Links:hsa-miR-873-5p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
CACUL1
chr10
118674167
118755249
-
ICAM1
chr19
10271093
10286615
+
IDS
chrX
149476988
149521096
-
NUDT3
chr6
34279679
34392669
-
EPHA4
chr2
221418027
221574202
-
TRIOBP
chr22
37697048
37776556
+
BCL2L11
chr2
111119378
111168445
+
SEPHS2
chr16
30443631
30445874
-
PFKFB3
chr10
6144934
6254644
+
PSD3
chr8
18527303
19084730
-
PRDM15
chr21
41798225
41879482
-
DLG3
chrX
70444835
70505490
+
ORAI1
chr12
121626550
121642677
+
LMBR1
chr7
156668946
156893216
-
TRIO
chr5
14143342
14532128
+
OTUB1
chr11
63985853
64001811
+
HDGF
chr1
156742109
156766925
-
FAM222B
chr17
28755978
28855232
-
TBX3
chr12
114670255
114684175
-
BCL9L
chr11
118893875
118925608
-
CTTNBP2NL
chr1
112396214
112463456
+
CENPX
chr17
82018702
82024107
-
SMG5
chr1
156249224
156282825
-
PLAGL2
chr20
32192504
32207743
-
BICRA
chr19
47608196
47703277
+
CSNK1E
chr22
38290691
38318084
-
TMEM179B
chr11
62787402
62790400
+
DBNDD1
chr16
90004871
90020128
-
ZXDB
chrX
57591652
57597545
+
APPL2
chr12
105173297
105236203
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000417
chr12
69644908
69656342
+
hsa_circ_0000987
chr2
30748452
30756180
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC002116.1
chr19
36008638
36014235
-
AC079781.5
chr7
97851688
97972985
-
AC084809.2
chr17
32905662
32906584
+
AC239868.1
chr1
149861271
149862504
+
AC245033.4
chr15
82533175
82540008
-
AL022311.1
chr22
37876148
37895563
+
AL049543.1
chr6
28587378
28591747
+
AL355987.2
chr9
136800366
136829466
+
GAS5
chr1
173858559
173868882
-
LINC01535
chr19
37251885
37265535
+
MALAT1
chr11
65497688
65506516
+
MIR4435-2HG
chr2
111006015
111523376
-
MIR503HG
chrX
134543119
134546642
-
NEAT1
chr11
65422774
65445540
+
SNHG15
chr7
44983023
44986961
-
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.